
Liarozole Dihydrochloride is identified as a modest ингибитор of P450 с IC50 of 2.2–6.0 μM and 260 nM for CYP26 and rat CYP17 respectively.
Liarozole Dihydrochloride is identified as a modest inhibitor of P450 with IC50 of 2.2–6.0 μM and 260 nM for CYP26 and rat CYP17 respectively.
Только для научно-исследовательского применения. Не предназначено для использования у пациентов или в качестве лекарственного средства.